Jacobs Levy Equity Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-152,732
| Closed | -$1.17M | – | 941 |
|
|
2023
Q4 | $1.17M | Sell |
152,732
-8,905
| -6% | -$68.4K | 0.01% | 688 |
|
|
2023
Q3 | $1.21M | Buy |
161,637
+31,856
| +25% | +$238K | 0.01% | 643 |
|
|
2023
Q2 | $1.08M | Buy |
129,781
+119,108
| +1,116% | +$992K | 0.01% | 684 |
|
|
2023
Q1 | $142K | Buy |
+10,673
| New | +$142K | ﹤0.01% | 922 |
|
|
2020
Q4 | – | Sell |
-8,695
| Closed | -$323K | – | 1016 |
|
|
2020
Q3 | $323K | Buy |
+8,695
| New | +$323K | ﹤0.01% | 878 |
|
|
2019
Q1 | – | Sell |
-5,624
| Closed | -$147K | – | 954 |
|
|
2018
Q4 | $147K | Buy |
+5,624
| New | +$147K | ﹤0.01% | 922 |
|
|
2018
Q3 | – | Sell |
-1,655
| Closed | -$95K | – | 983 |
|
|
2018
Q2 | $95K | Sell |
1,655
-694
| -30% | -$39.8K | ﹤0.01% | 994 |
|
|
2018
Q1 | $255K | Buy |
+2,349
| New | +$255K | ﹤0.01% | 888 |
|